|
|
Previous Article | Table of Contents | Next Article 
Inhibitory effect of all-trans retinoic acid on the growth of freshly
isolated myeloma cells via interference with interleukin-6 signal
transduction [see comments]
A Ogata, N Nishimoto, Y Shima, K Yoshizaki and T Kishimoto
Department of Medicine III, Osaka University Medical School, Japan.
We showed the dose-dependent growth inhibition by alltrans retinoic acid
(ATRA) of myeloma cells freshly isolated from patients. ATRA downregulated
the cell surface expression of interleukin-6 receptor (IL- 6R) and/or
glycoprotein (gp) 130. The growth-inhibitory activity of ATRA was well
correlated with that of anti-gp 130 antibody in every sample. Furthermore,
ATRA inhibited the production of IL-6 from both myeloma cells and marrow
stromal cells, and recombinant IL-6 (rIL-6) could partially recover the
myeloma cell growth that had been inhibited by ATRA. These data suggest
that ATRA may inhibit the proliferation of myeloma cells both by the
downregulation of IL-6R and gp130 expression on myeloma cells and by the
inhibition of IL-6 production from myeloma and stromal cells. Prednisolone
(PSL) and interferon-gamma (IFN-gamma) also inhibited the myeloma growth,
while their effects were different from those of ATRA on IL-6 R and gp130
expression, IL-6 production, and morphological change. The inhibitory
effect of ATRA on myeloma cell proliferation was observed in 10 of 14
samples obtained from eight patients, which suggests that ATRA may be a
potent new therapeutic agent for some myeloma patients.
Volume 84,
Issue 9,
pp. 3040-3046,
11/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Tabata, R. Tabata, Y. Kadokawa, S. Hisamori, M. Takahashi, M. Mishima, T. Nakano, and H. Kubo
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice
J. Immunol.,
July 1, 2007;
179(1):
708 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tabata, Y. Kadokawa, R. Tabata, M. Takahashi, K. Okoshi, Y. Sakai, M. Mishima, and H. Kubo
All-trans-Retinoic Acid Prevents Radiation- or Bleomycin-induced Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1352 - 1360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. D. Shingleton, D. Jones, X. Xu, T. E. Cawston, and A. D. Rowan
Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes
Rheumatology,
August 1, 2006;
45(8):
958 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tabata, H. Kubo, R. Tabata, M. Wada, K. Sakuma, M. Ichikawa, S. Fujita, T. Mio, and M. Mishima
All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system
Am J Physiol Lung Cell Mol Physiol,
March 1, 2006;
290(3):
L597 - L606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Douglas, E. Tracy, D. Tan, J. Yu, W. L. Hicks Jr., N. R. Rigual, T. R. Loree, Y. Wang, and H. Baumann
Development of Head and Neck Squamous Cell Carcinoma Is Associated With Altered Cytokine Responsiveness
Mol. Cancer Res.,
October 1, 2004;
2(10):
585 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Hjertner, H. Hjorth-Hansen, M. Borset, C. Seidel, A. Waage, and A. Sundan
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells
Blood,
January 15, 2001;
97(2):
516 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Masood, S. Nagpal, T. Zheng, J. Cai, A. Tulpule, D. L. Smith, and P. S. Gill
Kaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist
Blood,
November 1, 2000;
96(9):
3188 - 3194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sammons, N. Ahmed, M.A. Khokher, and H.T. Hassan
Mechanisms Mediating the Inhibitory Effect of All-Trans Retinoic Acid on Primitive Hematopoietic Stem Cells in Human Long-Term Bone Marrow Culture
Stem Cells,
May 1, 2000;
18(3):
214 - 219.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y.-H. Chen, D. Lavelle, J. DeSimone, S. Uddin, L. C. Platanias, and M. Hankewych
Growth Inhibition of a Human Myeloma Cell Line by All-trans Retinoic Acid Is Not Mediated Through Downregulation of Interleukin-6 Receptors but Through Upregulation of p21WAF1
Blood,
July 1, 1999;
94(1):
251 - 259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hallek, P. Leif Bergsagel, and K. C. Anderson
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Blood,
January 1, 1998;
91(1):
3 - 21.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Urashima, G. Teoh, D. Chauhan, Y. Hoshi, A. Ogata, S. P. Treon, R. L. Schlossman, and K. C. Anderson
Interleukin-6 Overcomes p21WAF1 Upregulation and G1 Growth Arrest Induced by Dexamethasone and Interferon-gamma in Multiple Myeloma Cells
Blood,
July 1, 1997;
90(1):
279 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. O'Brien and S. C. Manolagas
Isolation and Characterization of the Human gp130 Promoter. REGULATION BY STATS
J. Biol. Chem.,
June 6, 1997;
272(23):
15003 - 15010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Elizondo, J. Corchero, E. Sterneck, and F. J. Gonzalez
Feedback Inhibition of the Retinaldehyde Dehydrogenase Gene ALDH1 by Retinoic Acid through Retinoic Acid Receptor alpha and CCAAT/Enhancer-binding Protein beta
J. Biol. Chem.,
December 8, 2000;
275(50):
39747 - 39753.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|